Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,568 | -7,219 | -4,756 | -2,451 | -20,656 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 27 |
| Other Working Capital | 1,455 | 181 | 20 | -683 | 2,017 |
| Other Operating Activity | 516 | 458 | 128 | 69 | 11,320 |
| Operating Cash Flow | $-8,597 | $-6,579 | $-4,609 | $-3,064 | $-7,291 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | 64 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -1,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,000 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-936 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,672 | 6,670 | 2,787 | 1,839 | 850 |
| Other Financing Activity | -693 | -430 | -313 | -186 | -566 |
| Financing Cash Flow | $5,979 | $6,240 | $2,474 | $1,653 | $284 |
| Beginning Cash Position | 3,484 | 3,484 | 3,484 | 3,484 | 11,427 |
| End Cash Position | 865 | 3,144 | 1,349 | 2,072 | 3,484 |
| Net Cash Flow | $-2,619 | $-340 | $-2,135 | $-1,412 | $-7,943 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,597 | -6,579 | -4,609 | -3,064 | -7,291 |
| Free Cash Flow | -8,597 | -6,579 | -4,609 | -3,064 | -7,291 |